Cargando…
KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling
Hepatocellular carcinoma (HCC) is one of the most lethal malignancies with extremely poor prognosis. Therefore, revealing the critical molecules involved in HCC progression and prognosis is urgently needed. In this study, through combining public dataset and our cohort, we found a novel prognosis-re...
Autores principales: | Zhang, Shuhua, Xu, Jianqun, Cao, Huan, Jiang, Mi, Xiong, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810504/ https://www.ncbi.nlm.nih.gov/pubmed/35127520 http://dx.doi.org/10.3389/fonc.2021.808291 |
Ejemplares similares
-
CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation
por: Zhang, Shuhua, et al.
Publicado: (2022) -
CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway
por: Zhang, Shuhua, et al.
Publicado: (2019) -
In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L
por: Morishita, Masayo, et al.
Publicado: (2014) -
NSD1 in erythroid differentiation and leukemogenesis
por: Tauchmann, Samantha, et al.
Publicado: (2020) -
Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway
por: Chen, Yi, et al.
Publicado: (2022)